Hadasit Bio Revenue vs. Z Score

HDST Stock   53.00  5.40  9.25%   
Considering Hadasit Bio's profitability and operating efficiency indicators, Hadasit Bio may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in May. Profitability indicators assess Hadasit Bio's ability to earn profits and add value for shareholders.
For Hadasit Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hadasit Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hadasit Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hadasit Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hadasit Bio over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Hadasit Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hadasit Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hadasit Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Hadasit Bio Z Score vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Hadasit Bio's current stock value. Our valuation model uses many indicators to compare Hadasit Bio value to that of its competitors to determine the firm's financial worth.
Hadasit Bio is currently under evaluation in revenue category among related companies. It is one of the top stocks in z score category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hadasit Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hadasit Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hadasit Bio's earnings, one of the primary drivers of an investment's value.

Hadasit Revenue vs. Competition

Hadasit Bio is currently under evaluation in revenue category among related companies. Market size based on revenue of Health Care industry is currently estimated at about 2.47 Billion. Hadasit Bio adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.

Hadasit Z Score vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Hadasit Bio

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
null
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Hadasit Bio

Z Score

 = 

Sum Of

5 Factors

 = 
-1.4
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Hadasit Z Score Comparison

Hadasit Bio is currently under evaluation in z score category among related companies.

Hadasit Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Hadasit Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hadasit Bio will eventually generate negative long term returns. The profitability progress is the general direction of Hadasit Bio's change in net profit over the period of time. It can combine multiple indicators of Hadasit Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. HBL HADASIT is traded on Tel Aviv Stock Exchange in Israel.

Hadasit Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Hadasit Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hadasit Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hadasit Bio's important profitability drivers and their relationship over time.

Use Hadasit Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hadasit Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hadasit Bio will appreciate offsetting losses from the drop in the long position's value.

Hadasit Bio Pair Trading

Hadasit Bio Pair Trading Analysis

The ability to find closely correlated positions to Hadasit Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hadasit Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hadasit Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hadasit Bio to buy it.
The correlation of Hadasit Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hadasit Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hadasit Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hadasit Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Hadasit Bio position

In addition to having Hadasit Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Hadasit Stock analysis

When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
To fully project Hadasit Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Hadasit Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Hadasit Bio's income statement, its balance sheet, and the statement of cash flows.
Potential Hadasit Bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Hadasit Bio investors may work on each financial statement separately, they are all related. The changes in Hadasit Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hadasit Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.